Legislative Research: WI SB982 | 2021-2022 | Regular Session
Other Sessions
| Session | Title/Description | Last Action |
|---|---|---|
| 2023-2024 Regular Session (Failed) | An Act to repeal 943.13 (1m) (c) 5.; to amend 175.60 (2g) (a), 175.60 (5) (a) 6., 938.34 (14q), 938.78 (3), 939.632 (1) (e) 3., 941.235 (1), 943.13 (1m) (c) 4., 943.13 (2) (bm) 2. am., 968.255 (1) (a) 2. and 973.137 (1); and to create 941.236 of the ... [SB982 2023 Detail][SB982 2023 Text][SB982 2023 Comments] | 2024-04-15 Failed to pass pursuant to Senate Joint Resolution 1 |
| 2021-2022 Regular Session (Failed) | An Act to create 146.50 and 440.208 of the statutes; Relating to: prohibiting discrimination or retaliation against health care providers by health care entities and credentialing boards for ordering or discussing innovative or novel therapies. [SB982 2021 Detail][SB982 2021 Text][SB982 2021 Comments] | 2022-03-15 Failed to pass pursuant to Senate Joint Resolution 1 |
References Online
Legislative Citation
APA
WI SB982 | 2021-2022 | Regular Session. (2022, March 15). LegiScan. Retrieved November 18, 2024, from https://legiscan.com/WI/bill/SB982/2021
MLA
"WI SB982 | 2021-2022 | Regular Session." LegiScan. LegiScan LLC, 15 Mar. 2022. Web. 18 Nov. 2024. <https://legiscan.com/WI/bill/SB982/2021>.
Chicago
"WI SB982 | 2021-2022 | Regular Session." March 15, 2022 LegiScan. Accessed November 18, 2024. https://legiscan.com/WI/bill/SB982/2021.
Turabian
LegiScan. WI SB982 | 2021-2022 | Regular Session. 15 March 2022. https://legiscan.com/WI/bill/SB982/2021 (accessed November 18, 2024).
